0
2023
Advanced Clinical Decision Support Platforms Market

Advanced Clinical Decision Support Platforms Market

By Type (Therapeutic, Diagnostic), By Model (Knowledge based, Non Knowledge based), By Setting (Hospitals, Ambulatory care): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A13100
Feb 2023 | Pages: 241
Tables: 144
Charts: 65
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Advanced Clinical Decision Support Platforms Market Research, 2031

The global advanced clinical decision support platforms market size was valued at $496.4 million in 2021, and is projected to reach $1,175.0 million by 2031, growing at a CAGR of 9.0% from 2022 to 2031. An advanced clinical decision support platform is a comprehensive suite of tools and technologies designed to facilitate better clinical decision-making. It is designed to assist clinicians in making more informed, evidence-based decisions by combining data-driven analytics, clinical guidelines, and patient-specific data. Advanced decision support platforms provide a range of features such as patient-specific risk stratification, treatment protocols, predictive analytics, and patient-reported outcomes. These tools can alert the physician about potential errors, remind them to provide preventive care, help them to make diagnosis, and assist with treatment. They are also used to improve patient outcomes and reduce costs associated with care.

The advanced clinical decision support platforms market growth was slightly positive during the lockdown period owing to rise in the demand for evidence-based decisions for diagnosis and treatment purposes.

Advanced Clinical Decision Support Platforms Market

Historical overview

The advanced clinical decision support platforms market size was analyzed qualitatively and quantitatively from 2021 to 2030. The advanced clinical decision support platforms market experienced growth at a CAGR of around 8.7% from 2021 to 2030. Most of the growth during this period was derived from North America owing to the rise in the number of advanced clinical decision support platforms industry that provides advanced clinical decision support system, increase in adoption of electronic health records as well as well-established presence of domestic companies in the region.  

Market Dynamics

Growth of the global advanced clinical decision support platforms market is majorly driven by increase in incidence of medical error, increase in application of electronic health record system, rise in number of advanced clinical decision support platforms industry and increase in prevalence of chronic diseases. Increase in incidence of medical error is anticipated to drive the demand for advanced clinical decision support platform by professionals to get accurate information for diagnostic and therapeutic purposes. Thus, rising incidents of medical error is anticipated to boost the market growth. Medical errors are any preventable events that may cause or lead to inappropriate medical care or harm to a patient. Examples of medical errors include wrong diagnoses, improper or delayed treatment, or preventable adverse events. Clinical decision support systems (CDSS) are computer-based systems that help clinicians make decisions about patient care. CDSS can help to reduce medical errors by providing healthcare professionals with relevant and timely evidence-based information. For example, CDSS can provide alerts when a patient is prescribed a medication with potential interactions or adverse effects. It helps clinicians identify potential diagnosis or treatment options for a patient based on the patient's medical history and current symptoms. It also helps to ensure that the patient receives the most appropriate care and is not exposed to unnecessary tests or treatments.

Rise in the adoption of electronic health record system is anticipated to drive the growth of market. As advanced clinical decision support platform is a component of an electronic health record (EHR) system, thus, rise in application of EHR system in hospitals boosts the growth of market. In an EHR system, CDSS provides evidence-based recommendations and alerts to clinicians to help them make informed decisions about patient care. CDSS can help to reduce the risk of medical errors by providing timely, evidence-based information to clinicians. In addition, CDSS can help clinicians identify potential diagnosis or treatment options for a patient based on the patient's medical history and current symptoms. For instance, according to Center for Disease Control and Prevention, in January 2023, it was reported that, 88.2% of office-based physicians use any EHR system is and 77.8% of office-based physicians use a certified EHR system.

Increase in the number of geriatric populations is anticipated to augment the prevalence of chronic diseases such as heart disease and diabetes. Thus, this factor is anticipated to increase the demand for advanced clinical decision support platform among healthcare providers for correct diagnosis of diseases and accurate treatment for such chronic diseases. The elderly population is at an increased risk of developing chronic diseases due to age-related changes in the body, such as increase in cholesterol levels, decrease in elasticity of the arteries, and an accumulation of calcium deposits in the arteries. Thus, these factors are attributed to drive the market growth. For instance, according to the U.S. Census Bureau data published in December 2021, more than 56 million adults ages 65 i.e., 16.9% of population of the nation and by 2050, it is estimated to rise to 85.7 million. Moreover, according to report shared by World health Organization (WHO), it was reported that, population aged 60 years and over increased from 1 billion in 2020 to 1.4 billion in 2030 across the globe. As per the same report, it was estimated that, by 2050, people aged 60 years and older of the world is anticipated to double (2.1 billion).

Moreover, advanced clinical decision support platform aims at preventing cardiovascular diseases (CVD) by assessments of patients’ risk for developing CVD based on their history, risk factors, and clinical test results. Thus, rise in the prevalence of chronic diseases such as cardiovascular diseases is expected to increase the application of advanced clinical decision support system in hospitals and other healthcare settings. Thus, this factor is anticipated to drive the growth of market. For instance, according to the American Heart Association (AHA), it was reported that, the incidence of cardiovascular diseases (CVD) in U.S. men and women is 40% from 40–59 years, 75% from 60–79 years, and 86% in those above the age of 80

On the other hand, global advanced clinical decision support platform market expansion is constrained by worries about data security associated to CDSS that are in the cloud. Patient information is regarded as sensitive, and a high level of privacy must be upheld to ensure that only authorized individuals can access this information.

Legal frameworks have scrutinized patient information globally, for example, the data privacy regulations made law by Health Insurance Portability and Accountability Act (HIPAA). The EU Data Safeguarding Regulation, which has implications for the protection of sensitive health data, is also in effect in the European Union. Protected health information (PHI) of a patient is frequently prohibited from being transferred outside of the nation of origin. Public cloud is not recommended as it has the same security vulnerabilities as conventional IT systems. Even though private clouds offer more access to protocols and systems, the healthcare industry is not assured of its effectiveness.

As per study conducted by Ermetic, a cybersecurity investigation company, 81% of healthcare organizations have experienced cloud data security breaches in the last 18 months, as of June 2020. Around 31.25% of healthcare organizations experienced breaches where user access was denied. Major concerns related to data security also arise owing to the need for access to patient data through multiple departments. This, in order, creates security gaps, which can be misused by hackers to gain access to sensitive information. Thus, several large hospitals still prefer on-premises solutions over cloud-based solutions.

The COVID-19 pandemic had a significant impact on the advanced clinical decision support platform market. The demand for advanced clinical decision support platform has increased slightly due to the increased need for accurate and timely clinical decision making during the pandemic. The demand for advanced clinical decision support platform has risen due to the increasing demand for remote patient care and telehealth services. Advanced clinical decision support platform has enabled healthcare providers to make more informed decisions about patient care and provide better treatment options. In addition, advanced clinical decision support platform has allowed healthcare providers to provide more efficient and accurate clinical decision making for patient care. Furthermore, the pandemic has also created an increased demand for data-driven healthcare solutions. As advanced clinical decision support platform is one the data-driven solutions that can provide the necessary data to make more accurate and timely decisions. Thus, rise in application of advanced clinical decision support platform during pandemic fueled the market growth.

Segmental Overview

The advanced clinical decision support platforms market share is segmented into Type, Model, Setting, and Region. By type, the market is bifurcated into therapeutic and diagnostic. The diagnostic segment is further divided into hospitals and ambulatory care. Therapeutic segment is further classified into hospitals and ambulatory care. By model, the market is categorized into knowledge based and non-knowledge based. By setting, the market is segregated into hospital and ambulatory care. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By type, the market is bifurcated into therapeutic and diagnostic. The therapeutic segment dominated the market in 2021 and is expected to continue this trend during the advanced clinical decision support platforms market forecast period owing to rise in the prevalence of chronic diseases and increase in the adoption of advanced clinical decision support platforms for therapeutic purpose.

Advanced Clinical Decision Support Platforms Market

By model, the market is classified into knowledge-based and non-knowledge based. The knowledge-based segment dominated the market in 2021 and is expected to continue this trend during the forecast period owing to rise in number of product launch for knowledge-based clinical decision support system.

Advanced Clinical Decision Support Platforms Market

By setting, the market is divided into hospital and ambulatory care. The hospital segment dominated the market in 2021 and is expected to continue this trend during the forecast period owing to rise in expenditure by government to develop healthcare infrastructure and increase in number of hospitals.

Advanced Clinical Decision Support Platforms Market

North America advanced clinical decision support platforms market share is expected to grow during the forecast period owing to rise in the number of populations suffering from chronic disorders such as cancer, cardiovascular diseases, diabetes, and others. For instance, according to the American Cancer Society’s, in 2022, it was reported that, approximately 1,918,030 number of populations suffering from cancer. Thus, this factor is anticipated to drive the application advanced clinical decision support platform in hospitals for diagnostic and therapeutic purpose and boost the market growth. In addition, rise in product provision for clinical decision support platform in cancer fuels the advanced clinical decision support platforms market growth. For instance, Elsevier, a global information analytics company, provides ClinicalPath (formerly Via Oncology), a tool for Evidence-based oncology decision support and analytics for cancer care.

Asia-pacific advanced clinical decision support platform market is expected to witness growth during the forecast period owing to, economic development and low operating costs. The major driving factors for the market growth in this region include surge in prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes and rising geriatric population who are more susceptible to chronic diseases. Moreover, the increasing demand for cost-effective healthcare services and the need to reduce healthcare costs have been driving the growth of the advanced clinical decision support platform market in the Asia Pacific region. The expansion of healthcare IT infrastructure across the region has been driving the demand for clinical decision support platform.    

Advanced Clinical Decision Support Platforms Market

COMPETITION ANALYSIS

Some of the major companies that operate in the advanced clinical decision support platforms market include Siemens Healthineers, Wolters Kluwer, Zynx Health, Oracle Corporation, IBM Watson Health, NextGen Healthcare Inc., Veradigm Inc., Meditech, Epic Systems Corporation, and Elsevier B.V.

Some examples of product launch in the market

In January 2022, Epic launched Connection Hub, a new site for vendors to share their ability to interoperate with Epic software. The site open in January 2023 and allow vendor having connection to Epic to list their app and self-report, if they achieved successful data exchange.

Some examples of collaboration in the market

In March 2020, IBM Watson Health, a healthcare technology solutions company, and EBSCO Information Services (EBSCO), the leading provider of research databases, e-journals, magazine subscriptions, announced a strategic collaboration to enhance clinical decision support system (CDSS) and operations for healthcare providers and health systems

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the advanced clinical decision support platforms market analysis from 2021 to 2031 to identify the prevailing advanced clinical decision support platforms market opportunity
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the advanced clinical decision support platforms market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global advanced clinical decision support platforms market trends, key players, market segments, application areas, and market growth strategies.

Advanced Clinical Decision Support Platforms Market Report Highlights

Aspects Details
Market Size By 2031 USD 1.2 billion
Growth Rate CAGR of 9%
Forecast period 2021 - 2031
Report Pages 241
By Model
  • Knowledge based
  • Non Knowledge based
By Setting
  • Ambulatory care
  • Hospitals
By Type
  • Therapeutic
    • Setting
      • Hospitals
      • Ambulatory care
  • Diagnostic
    • Setting
      • Hospitals
      • Ambulatory care
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Wolters Kluwer, Siemens Healthineers, Veradigm Inc., IBM Watson Health, Zynx health, Oracle Corporation, NextGen Healthcare Inc., Relx Group, Meditech, Epic Systems Corporation
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Bargaining power of suppliers

      • 3.3.2. Bargaining power of buyers

      • 3.3.3. Threat of substitutes

      • 3.3.4. Threat of new entrants

      • 3.3.5. Intensity of rivalry

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Growth in incidence of medication error
        • 3.4.1.2. Increase in application of electronic health record system
        • 3.4.1.3. Rise in geriatric population and increase in prevalence of chronic diseases

      • 3.4.2. Restraints

        • 3.4.2.1. Data security concerns related to cloud based CDSS
        • 3.4.2.2. Increase in the incidence of data breach

      • 3.4.3. Opportunities

        • 3.4.3.1. Increase in number of adoptions of key strategies for development of market

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Therapeutic

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

      • 4.2.4. Therapeutic Advanced Clinical Decision Support Platforms Market by Setting

        • 4.2.4.1. Hospitals Market size and forecast, by region
        • 4.2.4.2. Ambulatory care Market size and forecast, by region
    • 4.3. Diagnostic

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

      • 4.3.4. Diagnostic Advanced Clinical Decision Support Platforms Market by Setting

        • 4.3.4.1. Hospitals Market size and forecast, by region
        • 4.3.4.2. Ambulatory care Market size and forecast, by region
  • CHAPTER 5: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Knowledge based

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Non Knowledge based

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

  • CHAPTER 6: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Hospitals

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Ambulatory care

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

  • CHAPTER 7: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Type

        • 7.2.2.1. North America Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
        • 7.2.2.2. North America Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
      • 7.2.3. Market size and forecast, by Model

      • 7.2.4. Market size and forecast, by Setting

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Type
          • 7.2.5.1.3. Market size and forecast, by Model
          • 7.2.5.1.4. Market size and forecast, by Setting
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Type
          • 7.2.5.2.3. Market size and forecast, by Model
          • 7.2.5.2.4. Market size and forecast, by Setting
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Type
          • 7.2.5.3.3. Market size and forecast, by Model
          • 7.2.5.3.4. Market size and forecast, by Setting
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Type

        • 7.3.2.1. Europe Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
        • 7.3.2.2. Europe Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
      • 7.3.3. Market size and forecast, by Model

      • 7.3.4. Market size and forecast, by Setting

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Type
          • 7.3.5.1.3. Market size and forecast, by Model
          • 7.3.5.1.4. Market size and forecast, by Setting
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Type
          • 7.3.5.2.3. Market size and forecast, by Model
          • 7.3.5.2.4. Market size and forecast, by Setting
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Type
          • 7.3.5.3.3. Market size and forecast, by Model
          • 7.3.5.3.4. Market size and forecast, by Setting
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Type
          • 7.3.5.4.3. Market size and forecast, by Model
          • 7.3.5.4.4. Market size and forecast, by Setting
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Type
          • 7.3.5.5.3. Market size and forecast, by Model
          • 7.3.5.5.4. Market size and forecast, by Setting
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Type
          • 7.3.5.6.3. Market size and forecast, by Model
          • 7.3.5.6.4. Market size and forecast, by Setting
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Type

        • 7.4.2.1. Asia-Pacific Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
        • 7.4.2.2. Asia-Pacific Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
      • 7.4.3. Market size and forecast, by Model

      • 7.4.4. Market size and forecast, by Setting

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Type
          • 7.4.5.1.3. Market size and forecast, by Model
          • 7.4.5.1.4. Market size and forecast, by Setting
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Type
          • 7.4.5.2.3. Market size and forecast, by Model
          • 7.4.5.2.4. Market size and forecast, by Setting
        • 7.4.5.3. India
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Type
          • 7.4.5.3.3. Market size and forecast, by Model
          • 7.4.5.3.4. Market size and forecast, by Setting
        • 7.4.5.4. Australia
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Type
          • 7.4.5.4.3. Market size and forecast, by Model
          • 7.4.5.4.4. Market size and forecast, by Setting
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Type
          • 7.4.5.5.3. Market size and forecast, by Model
          • 7.4.5.5.4. Market size and forecast, by Setting
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Type
          • 7.4.5.6.3. Market size and forecast, by Model
          • 7.4.5.6.4. Market size and forecast, by Setting
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Type

        • 7.5.2.1. LAMEA Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
        • 7.5.2.2. LAMEA Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
      • 7.5.3. Market size and forecast, by Model

      • 7.5.4. Market size and forecast, by Setting

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Type
          • 7.5.5.1.3. Market size and forecast, by Model
          • 7.5.5.1.4. Market size and forecast, by Setting
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Type
          • 7.5.5.2.3. Market size and forecast, by Model
          • 7.5.5.2.4. Market size and forecast, by Setting
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Type
          • 7.5.5.3.3. Market size and forecast, by Model
          • 7.5.5.3.4. Market size and forecast, by Setting
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Type
          • 7.5.5.4.3. Market size and forecast, by Model
          • 7.5.5.4.4. Market size and forecast, by Setting
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. IBM Watson Health

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Business performance

      • 9.1.7. Key strategic moves and developments

    • 9.2. Meditech

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

    • 9.3. NextGen Healthcare Inc.

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

    • 9.4. Siemens Healthineers

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

      • 9.4.7. Key strategic moves and developments

    • 9.5. Veradigm Inc.

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

      • 9.5.7. Key strategic moves and developments

    • 9.6. Wolters Kluwer

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

      • 9.6.7. Key strategic moves and developments

    • 9.7. Zynx health

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

    • 9.8. Oracle Corporation

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Business performance

      • 9.8.7. Key strategic moves and developments

    • 9.9. Epic Systems Corporation

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

      • 9.9.6. Key strategic moves and developments

    • 9.10. Relx Group

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

      • 9.10.6. Business performance

      • 9.10.7. Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 01. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 02. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR THERAPEUTIC, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. GLOBAL THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 04. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 05. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 06. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR DIAGNOSTIC, BY REGION, 2021-2031 ($MILLION)
    TABLE 07. GLOBAL DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 08. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 09. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 11. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR NON KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 14. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 15. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 17. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 18. NORTH AMERICA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 19. NORTH AMERICA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 20. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 21. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 22. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 23. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 24. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 25. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 26. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 27. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 28. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 29. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 30. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 31. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 32. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 33. EUROPE THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 34. EUROPE DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 35. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 36. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 37. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 38. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 39. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 40. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 41. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 42. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 43. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 44. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 45. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 46. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 47. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 48. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 49. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 50. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 51. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 52. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 53. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 54. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 55. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 56. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 57. ASIA-PACIFIC THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 58. ASIA-PACIFIC DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 59. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 60. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 61. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 62. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 63. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 64. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 65. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 66. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 67. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 68. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 69. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 70. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 71. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 72. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 73. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 74. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 75. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 76. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 77. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 78. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 79. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 80. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 81. LAMEA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 82. LAMEA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 83. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 84. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 85. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 86. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 87. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 88. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 89. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 90. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 91. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 92. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 93. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 94. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 95. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 96. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
    TABLE 97. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
    TABLE 98. IBM WATSON HEALTH: KEY EXECUTIVES
    TABLE 99. IBM WATSON HEALTH: COMPANY SNAPSHOT
    TABLE 100. IBM WATSON HEALTH: PRODUCT SEGMENTS
    TABLE 101. IBM WATSON HEALTH: PRODUCT PORTFOLIO
    TABLE 102. IBM WATSON HEALTH: KEY STRATERGIES
    TABLE 103. MEDITECH: KEY EXECUTIVES
    TABLE 104. MEDITECH: COMPANY SNAPSHOT
    TABLE 105. MEDITECH: SERVICE SEGMENTS
    TABLE 106. MEDITECH: PRODUCT PORTFOLIO
    TABLE 107. NEXTGEN HEALTHCARE INC.: KEY EXECUTIVES
    TABLE 108. NEXTGEN HEALTHCARE INC.: COMPANY SNAPSHOT
    TABLE 109. NEXTGEN HEALTHCARE INC.: PRODUCT SEGMENTS
    TABLE 110. NEXTGEN HEALTHCARE INC.: PRODUCT PORTFOLIO
    TABLE 111. SIEMENS HEALTHINEERS: KEY EXECUTIVES
    TABLE 112. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
    TABLE 113. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS
    TABLE 114. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
    TABLE 115. SIEMENS HEALTHINEERS: KEY STRATERGIES
    TABLE 116. VERADIGM INC.: KEY EXECUTIVES
    TABLE 117. VERADIGM INC.: COMPANY SNAPSHOT
    TABLE 118. VERADIGM INC.: PRODUCT SEGMENTS
    TABLE 119. VERADIGM INC.: PRODUCT PORTFOLIO
    TABLE 120. VERADIGM INC.: KEY STRATERGIES
    TABLE 121. WOLTERS KLUWER: KEY EXECUTIVES
    TABLE 122. WOLTERS KLUWER: COMPANY SNAPSHOT
    TABLE 123. WOLTERS KLUWER: SERVICE SEGMENTS
    TABLE 124. WOLTERS KLUWER: PRODUCT PORTFOLIO
    TABLE 125. WOLTERS KLUWER: KEY STRATERGIES
    TABLE 126. ZYNX HEALTH: KEY EXECUTIVES
    TABLE 127. ZYNX HEALTH: COMPANY SNAPSHOT
    TABLE 128. ZYNX HEALTH: PRODUCT SEGMENTS
    TABLE 129. ZYNX HEALTH: PRODUCT PORTFOLIO
    TABLE 130. ORACLE CORPORATION: KEY EXECUTIVES
    TABLE 131. ORACLE CORPORATION: COMPANY SNAPSHOT
    TABLE 132. ORACLE CORPORATION: PRODUCT SEGMENTS
    TABLE 133. ORACLE CORPORATION: PRODUCT PORTFOLIO
    TABLE 134. ORACLE CORPORATION: KEY STRATERGIES
    TABLE 135. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
    TABLE 136. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
    TABLE 137. EPIC SYSTEMS CORPORATION: SERVICE SEGMENTS
    TABLE 138. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
    TABLE 139. EPIC SYSTEMS CORPORATION: KEY STRATERGIES
    TABLE 140. RELX GROUP: KEY EXECUTIVES
    TABLE 141. RELX GROUP: COMPANY SNAPSHOT
    TABLE 142. RELX GROUP: SERVICE SEGMENTS
    TABLE 143. RELX GROUP: PRODUCT PORTFOLIO
    TABLE 144. RELX GROUP: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 01. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET (2022-2031)
    FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
    FIGURE 05. LOW BARGAINING POWER OF BUYERS
    FIGURE 06. LOW THREAT OF SUBSTITUTES
    FIGURE 07. LOW THREAT OF NEW ENTRANTS
    FIGURE 08. LOW INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET
    FIGURE 10. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR THERAPEUTIC, BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR DIAGNOSTIC, BY COUNTRY 2021-2031(%)
    FIGURE 13. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL      , 2021(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR KNOWLEDGE BASED    , BY COUNTRY 2021-2031(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR NON KNOWLEDGE BASED    , BY COUNTRY 2021-2031(%)
    FIGURE 16. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY COUNTRY 2021-2031(%)
    FIGURE 19. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY REGION, 2021
    FIGURE 20. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 21. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 22. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 23. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 24. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 25. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 26. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 27. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 28. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 29. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 30. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 31. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 32. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 33. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 34. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 35. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 36. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 37. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 38. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
    FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 43. COMPETITIVE DASHBOARD
    FIGURE 44. COMPETITIVE HEATMAP: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET
    FIGURE 45. TOP PLAYER POSITIONING, 2021
    FIGURE 46. IBM WATSON HEALTH: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 47. IBM WATSON HEALTH: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 48. IBM WATSON HEALTH: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 49. NEXTGEN HEALTHCARE INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 50. NEXTGEN HEALTHCARE INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 51. SIEMENS HEALTHINEERS: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 52. SIEMENS HEALTHINEERS: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 53. SIEMENS HEALTHINEERS: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 54. VERADIGM INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 55. VERADIGM INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 56. VERADIGM INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 57. WOLTERS KLUWER: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 58. WOLTERS KLUWER: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 59. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 60. ORACLE CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022
    FIGURE 61. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 62. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 63. RELX GROUP: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 64. RELX GROUP: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 65. RELX GROUP: REVENUE SHARE BY REGION, 2021 (%)

 
 

This section provides opinions of the top-level CXOs in the clinical decision support platforms market. According to CXOs, rise in geriatric population, the growing number of deaths caused by medical errors, evolving reimbursement methods, surge in need for data-driven technologies, and increase in number of emergency department (ED) visits are the main factors for the growth of the market. Healthcare delivery framework in the industry has significantly changed and tools based on CDSS technology that enhance the clinical performance. Furthermore, the increase in global population has led to decrease in the ratio of individuals to that of the physicians.

Moreover, increase in the adoption of electronic health records by hospitals & clinics and rise in awareness among the health professionals regarding importance & usage of electronic health record and clinical decision support system contribute to the growth of market. Rise in number of adoptions of key strategies such as acquisition, partnership, agreement, and business expansion by market players who provide clinical decision support system drives the market growth. In addition, surge in number of product launch for clinical decision support system is attributed to boost the market growth. For instance, in January 2021, Wolters Kluwer, a global provider of professional information, software solutions, and services for clinicians, announced the launch of Lippincott Connect, an all-in-one, digital learning solution that reinvents the traditional medical textbook as a natively digital experience.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. North America is the largest regional market for Advanced Clinical Decision Support Platforms.

A. The key trends in the Advanced Clinical Decision Support Platforms market are by technological advancement in the development of different clinical decision support systems.

A. The key players operating in the global Advanced Clinical Decision Support Platforms market are Siemens Healthineers, Wolters Kluwer, Zynx Health, Oracle Corporation, IBM Watson Health, NextGen Healthcare Inc., Veradigm Inc., Meditech, Epic Systems Corporation, and Elsevier B.V.

A. Yes, the competitive landscape is included in the Advanced Clinical Decision Support Platforms Market report

A. Asia-Pacific is expected to register the highest CAGR of 10.2% from 2022 to 2031, owing to rise in expenditure by government organizations to develop the healthcare sector,and increase in the prevalence of chronic diseases

A. The total market value of Advanced Clinical Decision Support Platforms market is $496.4 million in 2021.

A. The forecast period in the report is from 2022 to 2031

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Advanced Clinical Decision Support Platforms Market

Start reading instantly.
This Report and over 67,069+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers